Róbert Wessman is known for his clear focus and his ability to successfully combine operational efficiency and external growth through strategic acquisitions. His ambitions and policies have been clear from the beginning, to facilitate patients access to high quality drugs all over the world.
Aztiq, led by Róbert Wessman, focuses on investments in pharmaceutical and health-related industries. Aztiq is founded on the belief that everyone has the right to medicine, regardless of financial means. Aztiq’s owners aspire to build a scientific community that focuses on improving the health of people around the world.
Róbert Wessman is the CEO of Alvogen which is an international pharmaceutical company based in US. Alvogen specializes in the development and production of generic drugs, over-the-counter drugs and biotech drugs. The business is based on a solid foundation and Alvogen's subsidiaries have a long history.